Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

6 structures for O95551

Entry ID Method Resolution Chain Position Source
5INO X-ray 321 A A/B 108-362 PDB
5J3P X-ray 310 A A/B 113-362 PDB
5J3S X-ray 340 A A 113-362 PDB
6Q00 X-ray 085 A B 25-66 PDB
6Q01 X-ray 085 A C/D 25-66 PDB
AF-O95551-F1 Predicted AlphaFoldDB

298 variants for O95551

Variant ID(s) Position Change Description Diseaes Association Provenance
CA3658284
RCV001332149
rs760554150
33 A>S Autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome due to TUD deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs879255601
CA10576344
RCV000211707
138 S>* Autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome due to TUD deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA3658004
rs142438588
RCV003149159
317 R>* Autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome due to TUD deficiency Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV001169848
rs770844602
2 E>* No ClinVar
dbSNP
CA3658322
rs201104912
2 E>D No ClinGen
1000Genomes
ExAC
gnomAD
CA3658324
rs770844602
2 E>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3658321
rs777517528
3 L>* No ClinGen
ExAC
gnomAD
CA362973671
rs777517528
3 L>W No ClinGen
ExAC
gnomAD
rs778744134
CA3658318
5 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA362973635
rs1383090282
5 S>N No ClinGen
gnomAD
CA3658315
RCV000950144
rs61760186
6 C>F No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs61760186
CA3658316
6 C>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3658317
rs61760186
6 C>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1267394077
CA362973590
7 L>P No ClinGen
gnomAD
CA362973575
rs1386987037
8 E>A No ClinGen
TOPMed
rs764469672
CA3658311
8 E>K No ClinGen
ExAC
CA136140254
rs1001662438
9 G>A No ClinGen
Ensembl
rs1334570797
CA362973551
10 G>R No ClinGen
gnomAD
rs776653065
CA362973528
11 R>K No ClinGen
ExAC
gnomAD
rs776653065
CA3658306
11 R>M No ClinGen
ExAC
gnomAD
CA3658305
rs770777577
11 R>S No ClinGen
ExAC
gnomAD
rs776653065
CA3658307
11 R>T No ClinGen
ExAC
gnomAD
rs746736116
CA3658304
12 E>K No ClinGen
ExAC
TOPMed
gnomAD
COSM3719280
rs771868751
CA3658302
14 A>V haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1291385423
CA362973455
15 E>K No ClinGen
gnomAD
CA362973398
rs1460630158
18 G>D No ClinGen
gnomAD
CA362973374
rs778549935
19 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA136140224
rs796178595
20 P>A No ClinGen
Ensembl
CA362973329
rs779185834
21 E>D No ClinGen
TOPMed
gnomAD
rs1582428319
CA362973309
22 V>G No ClinGen
Ensembl
rs199594700
CA3658299
22 V>M No ClinGen
1000Genomes
ExAC
gnomAD
CA362973304
rs1199474645
23 K>* No ClinGen
gnomAD
CA362973301
rs1433893910
23 K>R No ClinGen
gnomAD
rs753545235
CA3658297
24 K>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs779514628
CA3658296
24 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs764713488
CA3658294
26 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs764713488
CA3658293
26 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1582428295
CA362973251
27 L>R No ClinGen
Ensembl
rs765307607
CA3658290
28 L>R No ClinGen
ExAC
gnomAD
rs146127613
CA3658291
RCV000959613
28 L>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs776938646
CA3658287
31 E>A No ClinGen
ExAC
gnomAD
CA362973196
rs1439730417
31 E>D No ClinGen
gnomAD
CA3658286
rs761457468
32 F>* No ClinGen
ExAC
gnomAD
TCGA novel 32 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3658285
rs760554150
33 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA362973142
rs1462495884
34 S>L No ClinGen
TOPMed
CA362973113
rs1383943146
36 A>T No ClinGen
gnomAD
rs890380136
CA136140098
37 S>G No ClinGen
TOPMed
gnomAD
rs1276764084
CA362973062
38 C>* No ClinGen
TOPMed
gnomAD
rs200485971
CA3658280
39 D>G No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 40 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1562152158
CA362973045
40 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA3658278
rs748758001
41 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA362973006
rs1248950116
42 V>G No ClinGen
gnomAD
CA3658277
rs779796863
44 Q>* No ClinGen
ExAC
TOPMed
gnomAD
rs1463858701
CA362972974
44 Q>H No ClinGen
gnomAD
rs200802722
CA3658276
45 C>R No ClinGen
ExAC
TOPMed
gnomAD
rs777996628
CA3658274
48 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA3658272
COSM3829765
rs753218291
52 W>* breast [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA3658271
rs765688086
53 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1225690968
CA362972797
54 M>I No ClinGen
gnomAD
CA3658270
rs35306604
54 M>R No ClinGen
ExAC
gnomAD
CA362972801
rs35306604
54 M>T No ClinGen
ExAC
gnomAD
CA3658251
rs754004696
57 A>P No ClinGen
ExAC
gnomAD
CA362972684
rs1408536242
57 A>V No ClinGen
TOPMed
CA362972676
rs1416104452
58 L>P No ClinGen
gnomAD
CA362972678
rs1474007893
58 L>V No ClinGen
gnomAD
CA3658250
rs35744230
RCV000881100
59 N>D No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1356554993
CA362972661
59 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1178964711
CA362972619
61 Y>* No ClinGen
TOPMed
gnomAD
CA362972627
rs1253362218
61 Y>C No ClinGen
gnomAD
rs980296055
CA362972577
64 P>A No ClinGen
TOPMed
gnomAD
CA136139950
rs980296055
64 P>T No ClinGen
TOPMed
gnomAD
rs767799429
CA3658247
65 P>Q No ClinGen
ExAC
gnomAD
CA362972546
rs1354039132
66 V>E No ClinGen
gnomAD
rs761730495
CA3658246
66 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA3658245
rs774266776
67 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA3658244
rs764184914
67 E>V No ClinGen
ExAC
TOPMed
gnomAD
rs762798149
CA3658243
68 E>K No ClinGen
ExAC
gnomAD
CA136139924
rs969311995
70 A>P No ClinGen
Ensembl
CA362972481
rs1440189135
70 A>V No ClinGen
gnomAD
rs769203472
CA3658241
72 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA136139920
rs1021778454
72 E>K No ClinGen
TOPMed
CA362972434
rs1440749528
73 R>C No ClinGen
TOPMed
gnomAD
CA362972429
rs1324504135
73 R>H No ClinGen
gnomAD
CA362972419
rs1392767053
74 R>Q No ClinGen
TOPMed
gnomAD
CA362972409
rs1474863338
75 P>A No ClinGen
TOPMed
rs776300645
CA3658239
75 P>L No ClinGen
ExAC
gnomAD
rs1458233192
CA362972363
77 T>I No ClinGen
gnomAD
rs779231725
CA3658237
78 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA3658235
rs769270221
79 S>F No ClinGen
ExAC
TOPMed
gnomAD
COSM595233
CA3658234
rs143844222
80 E>K lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA362972306
rs756169471
81 P>H No ClinGen
ExAC
gnomAD
rs756169471
CA3658232
81 P>L No ClinGen
ExAC
gnomAD
rs780551850
CA3658233
81 P>S No ClinGen
ExAC
gnomAD
rs781614136
CA3658230
82 K>N No ClinGen
ExAC
gnomAD
rs1031124199
CA136139852
83 T>I No ClinGen
TOPMed
CA3658229
rs757539692
84 Y>C No ClinGen
ExAC
gnomAD
CA362972252
rs1209200614
84 Y>D No ClinGen
gnomAD
CA362972248
rs757539692
84 Y>F No ClinGen
ExAC
gnomAD
rs1355309536
CA362989299
85 V>A No ClinGen
gnomAD
CA362989218
rs1436699320
89 N>D No ClinGen
TOPMed
gnomAD
CA3658191
RCV000901410
rs61757564
89 N>S No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3658190
rs746383136
90 E>D No ClinGen
ExAC
gnomAD
CA136165125
rs895488148
97 T>A No ClinGen
TOPMed
rs747049195
CA136165103
97 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs747049195
CA3658187
97 T>N No ClinGen
ExAC
TOPMed
gnomAD
CA362988997
rs1211200558
98 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA3658186
rs375353513
99 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs758629003
CA3658185
102 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs758629003
CA362988884
102 P>T No ClinGen
ExAC
TOPMed
gnomAD
CA362988804
rs1361743035
104 E>K No ClinGen
TOPMed
CA136165080
rs1026452149
105 D>Y No ClinGen
TOPMed
gnomAD
CA3658183
rs372058337
106 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3658182
rs565103897
107 Q>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA362988754
rs565103897
107 Q>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1269374875
CA362988681
111 G>V No ClinGen
gnomAD
CA362988661
rs1314646872
113 M>L No ClinGen
gnomAD
CA3658179
rs749917446
116 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA3658178
rs749917446
116 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs993194887
CA136165048
117 I>V No ClinGen
TOPMed
gnomAD
CA3658176
rs761522826
121 I>T No ClinGen
ExAC
gnomAD
CA362988525
rs1582422856
122 D>N No ClinGen
Ensembl
rs1413293519
CA362988509
123 G>R No ClinGen
gnomAD
rs1439964797
CA362988487
124 L>F No ClinGen
gnomAD
rs759933045
CA3658173
125 D>E No ClinGen
ExAC
gnomAD
CA3658174
rs765648402
125 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA362988473
rs1441592351
126 L>I No ClinGen
gnomAD
CA136164976
rs941592436
128 N>D No ClinGen
TOPMed
gnomAD
rs369086085
CA3658172
128 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1562148727
RCV000760521
CA362988423
130 S>* No ClinGen
ClinVar
Ensembl
dbSNP
rs747139051
CA3658170
133 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs377119756
CA362988400
134 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs377119756
CA3658169
134 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA136164949
rs772244923
134 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs772244923
CA3658168
COSM1076517
134 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3658164
rs749041076
136 V>G No ClinGen
ExAC
rs754787459
CA3658165
136 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs780006118
CA3658163
137 C>S No ClinGen
ExAC
TOPMed
gnomAD
CA3658162
rs756022937
138 S>F No ClinGen
ExAC
gnomAD
rs1349398619
CA362988357
141 A>G No ClinGen
gnomAD
TCGA novel 141 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1485863094
CA362988333
143 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1434340879
CA362988328
144 S>G No ClinGen
gnomAD
rs200729372
CA3658138
144 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA136164311
rs267600903
147 V>G No ClinGen
Ensembl
rs758114038
CA3658137
149 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1460830651
CA362988293
149 F>S No ClinGen
TOPMed
gnomAD
CA136164293
rs144064433
151 Q>L No ClinGen
ESP
CA3658136
rs754324675
152 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs754324675
CA136164285
152 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs760887221
CA3658134
153 V>I No ClinGen
ExAC
gnomAD
CA136164279
rs1047009007
155 P>R No ClinGen
Ensembl
CA362988252
rs1186686017
156 P>S No ClinGen
gnomAD
rs1167547323
CA823329059
160 Y>* No ClinGen
TOPMed
rs1193684170
CA362988219
160 Y>F No ClinGen
gnomAD
CA3658131
rs761991069
161 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1336565250
CA362988200
163 K>R No ClinGen
TOPMed
CA3658128
rs35977478
VAR_051464
166 S>G No ClinGen
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs991220151
CA136164219
167 N>D No ClinGen
Ensembl
CA136164216
rs934618015
172 T>A No ClinGen
TOPMed
gnomAD
CA3658125
rs769599954
172 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA362987139
rs1323626479
174 H>Q No ClinGen
TOPMed
CA3658108
rs775719133
174 H>R No ClinGen
ExAC
gnomAD
rs1224824604
CA362987134
175 E>K No ClinGen
TOPMed
CA3658107
rs765344588
176 E>V No ClinGen
ExAC
gnomAD
TCGA novel 177 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1562147316
CA362986985
180 T>I No ClinGen
Ensembl
CA3658105
rs776274216
182 I>T No ClinGen
ExAC
gnomAD
CA362986964
rs1469174828
182 I>V No ClinGen
TOPMed
gnomAD
rs770963867
CA3658104
CA362986929
183 M>I No ClinGen
ExAC
gnomAD
CA136162524
rs899145526
186 K>I No ClinGen
gnomAD
CA362986879
rs899145526
186 K>R No ClinGen
gnomAD
CA362986848
rs1209809150
RCV000734588
187 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
CA362986791
rs1582420627
189 V>G No ClinGen
Ensembl
rs746943158
CA3658103
189 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1282064941
CA362986740
191 L>F No ClinGen
gnomAD
CA362986757
rs1037727835
191 L>I No ClinGen
gnomAD
CA136162511
rs1037727835
191 L>V No ClinGen
gnomAD
CA3658101
rs370316626
193 S>C No ClinGen
ESP
ExAC
gnomAD
rs1304498503
CA362986631
196 I>L No ClinGen
gnomAD
CA3658098
rs778750350
198 P>L No ClinGen
ExAC
gnomAD
CA136162475
rs778750350
198 P>R No ClinGen
ExAC
gnomAD
rs267600902
CA136162486
198 P>S No ClinGen
Ensembl
TCGA novel 199 F>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1432116169
CA362986525
201 S>N No ClinGen
TOPMed
gnomAD
rs746303603
CA3658096
206 R>G No ClinGen
ExAC
gnomAD
CA362986387
rs1399660567
207 N>S No ClinGen
gnomAD
rs1582420576
CA362986373
208 L>I No ClinGen
Ensembl
rs781406884
CA3658095
209 L>S No ClinGen
ExAC
gnomAD
CA3658094
rs757575420
210 C>Y No ClinGen
ExAC
gnomAD
CA362986296
rs1449771774
211 V>A No ClinGen
Ensembl
rs752083509
CA3658093
212 H>R No ClinGen
ExAC
gnomAD
rs1186961817
CA362986261
212 H>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1129644
CA362985845
214 N>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA362985834
rs1272661971
216 S>* No ClinGen
TOPMed
CA3658073
rs757593327
217 G>E No ClinGen
ExAC
gnomAD
CA362985814
rs1309661723
219 E>V No ClinGen
gnomAD
rs778299111
CA3658071
224 T>R No ClinGen
ExAC
TOPMed
gnomAD
CA362985767
rs1285933137
226 H>R No ClinGen
TOPMed
rs758885890
CA3658070
232 G>R No ClinGen
ExAC
gnomAD
CA362985719
rs1298424370
233 H>L No ClinGen
gnomAD
CA362985720
rs1377771801
233 H>Y No ClinGen
gnomAD
CA3658068
rs752837935
234 A>V No ClinGen
ExAC
gnomAD
CA3658067
rs375948102
235 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1461764792
CA362985704
236 E>K No ClinGen
TOPMed
gnomAD
rs1461764792
CA362985703
236 E>Q No ClinGen
TOPMed
gnomAD
rs752399511
CA136161580
237 R>* Variant assessed as Somatic; 4.621e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA136161579
rs893794246
237 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs766587845
CA3658064
238 M>L No ClinGen
ExAC
gnomAD
rs1178017250
CA362985685
239 N>H No ClinGen
gnomAD
CA362985662
rs1361017980
242 K>E No ClinGen
gnomAD
rs750223762
CA3658062
CA362985649
243 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs760589504
CA3658063
243 M>T No ClinGen
ExAC
gnomAD
TCGA novel 243 M>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1198481964
CA362985644
244 V>D No ClinGen
gnomAD
VAR_022634
CA3658060
rs2294689
249 Q>E No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA362985594
rs1307016253
251 A>T No ClinGen
TOPMed
gnomAD
rs768064857
CA3658058
251 A>V No ClinGen
ExAC
gnomAD
CA362985579
rs1370812223
253 E>G No ClinGen
gnomAD
rs776721112
CA136161528
255 A>P No ClinGen
Ensembl
CA362985557
rs1562146685
257 V>F No ClinGen
Ensembl
CA3658057
rs762485056
258 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1396365352
CA362985551
258 I>V No ClinGen
gnomAD
CA3658056
rs775044884
259 F>L No ClinGen
ExAC
gnomAD
rs769412827
CA3658055
259 F>S No ClinGen
ExAC
gnomAD
CA362985511
rs747429858
264 N>S No ClinGen
ExAC
gnomAD
rs747429858
CA3658054
264 N>T No ClinGen
ExAC
gnomAD
CA362985492
rs1406127234
267 D>A No ClinGen
TOPMed
gnomAD
CA362985490
rs1406127234
267 D>V No ClinGen
TOPMed
gnomAD
rs772352587
CA3658052
268 R>* No ClinGen
ExAC
TOPMed
gnomAD
CA3658051
VAR_022635
rs17249952
268 R>Q No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel 271 T>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs746102191
CA3658026
273 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA362984880
rs1361681534
274 G>R No ClinGen
TOPMed
rs1297587138
CA362984860
275 G>S No ClinGen
gnomAD
rs139085454
CA3658025
278 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA362984762
rs1036211332
279 N>K No ClinGen
gnomAD
rs375654749
CA3658024
279 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3658022
rs763995072
280 I>N No ClinGen
ExAC
gnomAD
CA362984752
rs763995072
280 I>T No ClinGen
ExAC
gnomAD
rs751347138
CA3658023
280 I>V No ClinGen
ExAC
gnomAD
rs763334299
CA136160301
282 D>A No ClinGen
Ensembl
CA136160302
rs906748342
282 D>Y No ClinGen
TOPMed
gnomAD
CA362984695
rs1477094205
283 V>I No ClinGen
gnomAD
CA362984612
rs1261840388
284 W>* No ClinGen
gnomAD
CA136160299
rs949915126
286 F>S No ClinGen
TOPMed
gnomAD
RCV000238988
rs758350133
CA3658021
287 L>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA362984377
rs1562145924
292 H>R No ClinGen
Ensembl
CA3658018
rs544356367
293 C>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA136160259
rs1056155317
294 Q>H No ClinGen
Ensembl
rs758993809
CA3658017
294 Q>R No ClinGen
ExAC
gnomAD
CA362984220
rs1293815679
298 D>E No ClinGen
TOPMed
gnomAD
CA362984232
rs1317295167
298 D>Y No ClinGen
gnomAD
rs1415525607
CA362984178
300 Q>R No ClinGen
gnomAD
rs1465620409
CA362984163
301 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 302 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs774768351
CA3658013
305 L>F No ClinGen
ExAC
gnomAD
CA3658012
rs77273535
RCV000891730
VAR_076867
307 I>V slightly decreased phosphodiesterase activity [UniProt] No ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3658011
rs200729725
308 T>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs545117739
CA3658010
310 A>T No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 310 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3658009
rs770016841
312 K>E No ClinGen
ExAC
gnomAD
COSM1076512
rs745911675
CA3658008
314 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs781613923
CA3658007
314 R>H No ClinGen
ExAC
gnomAD
rs758067744
CA3658002
318 I>L No ClinGen
ExAC
TOPMed
gnomAD
rs752649752
CA3658001
322 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA3658000
rs765115330
323 A>V No ClinGen
ExAC
rs1273777339
CA362983817
325 E>K No ClinGen
gnomAD
CA362983800
rs1235015365
326 E>G No ClinGen
gnomAD
rs1244337335
CA362983772
329 I>V No ClinGen
gnomAD
CA3657997
rs775886529
332 R>* No ClinGen
ExAC
gnomAD
CA362983737
rs1445083090
332 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1327192432
CA362983706
335 D>A No ClinGen
gnomAD
TCGA novel 335 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA136160156
rs976894285
336 L>V No ClinGen
Ensembl
rs148051522
CA3657994
337 L>F No ClinGen
1000Genomes
ExAC
gnomAD
rs148051522
CA136160146
337 L>V No ClinGen
1000Genomes
ExAC
gnomAD
CA362983642
rs1365231068
341 K>T No ClinGen
gnomAD
TCGA novel 342 L>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1176359807
CA362983605
344 C>S No ClinGen
gnomAD
rs199528335
CA3657992
345 G>D No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3657993
rs202040495
345 G>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3657991
rs776172419
346 R>G No ClinGen
ExAC
CA136160118
rs965971283
347 F>L No ClinGen
Ensembl
rs367700182
CA3657988
349 S>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1215805990
CA362983523
349 S>T No ClinGen
TOPMed
rs199602263
CA3657987
350 D>N No ClinGen
1000Genomes
ExAC
gnomAD
rs1425244849
CA362983481
352 W>* No ClinGen
TOPMed
gnomAD
CA362983479
rs1425244849
352 W>C No ClinGen
TOPMed
gnomAD
CA3657986
rs770848492
353 G>V No ClinGen
ExAC
gnomAD
CA3657985
rs747265150
356 C>Y No ClinGen
ExAC
gnomAD
CA362983414
rs1376645761
358 L>F No ClinGen
gnomAD
rs143559471
CA3657984
358 L>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 359 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA362983387
rs1304547585
360 I>T No ClinGen
gnomAD
rs771928592
CA3657983
361 I>M No ClinGen
ExAC
gnomAD
TCGA novel 363 L>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

1 associated diseases with O95551

[MIM: 616949]: Spinocerebellar ataxia, autosomal recessive, 23 (SCAR23)

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia. {ECO:0000269|PubMed:24658003}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia. {ECO:0000269|PubMed:24658003}. Note=The disease is caused by variants affecting the gene represented in this entry.

1 regional properties for O95551

Type Name Position InterPro Accession
domain Endonuclease/exonuclease/phosphatase 118 - 351 IPR005135

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Nucleus, PML body
  • Nucleus, nucleolus
  • Cytoplasm
  • Localizes to nucleolar cavities following stress; localization to nucleolus is dependent on PML protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
aggresome An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
PML body A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.

7 GO annotations of molecular function

Name Definition
5'-tyrosyl-DNA phosphodiesterase activity Catalysis of the hydrolysis of 5'-phosphotyrosyl groups formed as covalent intermediates (in DNA backbone breakage) between DNA topoisomerase II and DNA.
magnesium ion binding Binding to a magnesium (Mg) ion.
manganese ion binding Binding to a manganese ion (Mn).
nuclease activity Catalysis of the hydrolysis of ester linkages within nucleic acids.
single-stranded DNA binding Binding to single-stranded DNA.
transcription corepressor activity A transcription coregulator activity that represses or decreases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Corepressors often act by altering chromatin structure and modifications. For example, one class of transcription corepressors modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators.
tyrosyl-RNA phosphodiesterase activity Catalysis of the hydrolysis of a 5' tyrosyl-RNA phosphodiester bond between a protein and RNA. In picornaviruses, this covalent bond connects VPg, a viral-encoded protein essential for RNA replication, to the 5' end of all nascent picornavirus genomes; it is cleaved from viral RNA prior to its engaging in protein synthesis.

3 GO annotations of biological process

Name Definition
cell surface receptor signaling pathway The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
double-strand break repair The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix.
neuron development The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A7YWI9 TDP2 Tyrosyl-DNA phosphodiesterase 2 Bos taurus (Bovine) PR
Q9JJX7 Tdp2 Tyrosyl-DNA phosphodiesterase 2 Mus musculus (Mouse) PR
Q3T1H5 Tdp2 Tyrosyl-DNA phosphodiesterase 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MELGSCLEGG REAAEEEGEP EVKKRRLLCV EFASVASCDA AVAQCFLAEN DWEMERALNS
70 80 90 100 110 120
YFEPPVEESA LERRPETISE PKTYVDLTNE ETTDSTTSKI SPSEDTQQEN GSMFSLITWN
130 140 150 160 170 180
IDGLDLNNLS ERARGVCSYL ALYSPDVIFL QEVIPPYYSY LKKRSSNYEI ITGHEEGYFT
190 200 210 220 230 240
AIMLKKSRVK LKSQEIIPFP STKMMRNLLC VHVNVSGNEL CLMTSHLEST RGHAAERMNQ
250 260 270 280 290 300
LKMVLKKMQE APESATVIFA GDTNLRDREV TRCGGLPNNI VDVWEFLGKP KHCQYTWDTQ
310 320 330 340 350 360
MNSNLGITAA CKLRFDRIFF RAAAEEGHII PRSLDLLGLE KLDCGRFPSD HWGLLCNLDI
IL